Clinical Trial Update: Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of temozolomide for leptomeningeal metastases from solid tumors or lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastases

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Brain Tumors, Central Nervous System Tumors | Phase 2 | Status: TERMINATED